The Food and Drug Administration (FDA) has granted emergency use authorization (EUA) to Rutgers’ RUCDR Infinite Biologics and its collaborators for a new collection approach that utilizes saliva as the primary test biomaterial for the SARS-CoV-2 coronavirus, the first such approval granted by the federal agency. “Saliva testing will help with the global shortage of swabs for sampling and increase testing […]
Recent Posts
- DIM: A Breakthrough Natural Compound for Preventing Tooth Decay
- Neuromuscular Dentistry & Myocentric Mandate: Boosting Systemic Health Beyond Occlusion
- Vasa Denticity ( Dentkart)Buys 51% of IDS Denmed, Creating India’s Largest Dental Supply Network
- “Every Extraction is a Vascular Event”: A Wake-up Call for Dental Surgeons
- Your Journey into AI, ML, and Digital Dentistry: Career Paths for New Dental Grads
Archives